Last updated: May 25, 2026
Tirosint Suppliers: Who Manufactures and Supplies Levothyroxine Sodium Capsules (US and Global Sources)?
Executive summary: Tirosint (levothyroxine sodium) is supplied through a branded product supply chain led by IBSA Pharma in the US and internationally. Core supplier roles break down into (1) API sourcing for levothyroxine sodium, (2) capsule and packaging manufacturing, and (3) specialty logistics and distribution. Public, decision-grade “named supplier” granularity depends on FDA labeling, Orange Book manufacturing/distribution statements, and product-specific distribution records, which are not provided in the prompt.
What is the supply chain for Tirosint (levothyroxine) in the US?
Answer (high level): The Tirosint supply chain consists of IBSA (brand owner/holder and typically the marketing authorization holder), with contract manufacturing for drug product and packaging, and levothyroxine sodium API sourced from qualified chemical producers. Distributor entities handle wholesale distribution to pharmacies and health systems.
What companies supply the Tirosint active ingredient levothyroxine sodium?
Answer (high level): Levothyroxine sodium is a commodity API produced by multiple chemical manufacturers under supplier qualification programs. For Tirosint, the actual named API suppliers vary by lot and are typically not fully enumerated in public sources unless captured in FDA filings or supplier-specific disclosures.
Key supply-chain roles for API (levothyroxine sodium)
- API manufacture (chemical synthesis and crystallization control)
- Impurity profile control (iodinated impurities, elemental impurities)
- Particle size and polymorph control (affects dissolution)
- Finished dosage compatibility (capsule filling and stability)
Who manufactures and packages Tirosint capsules?
Answer (high level): Tirosint is manufactured and packaged under contract and/or internal manufacturing networks managed by the marketing authorization holder. The US product is distributed under the brand holder’s label, with manufacturing sites referenced in product labeling and FDA listings.
Dosage form and packaging implications for suppliers
- Softgel-to-tablet differentiation: Tirosint is a capsule formulation (gelatin-based dosage presentation)
- Tamper evidence and blister/bottle packaging
- Stability requirements tied to capsule shell and moisture control
What does the FDA Orange Book list for Tirosint manufacturing and labeling?
Answer (high level): The Orange Book typically lists the application holder and patent/exclusivity data. Manufacturing and packaging site names can appear in label sections and establishment records, but “supplier” (API vendor) is usually not exhaustively stated.
What is Tirosint’s distribution network (wholesale suppliers)?
Answer (high level): Distribution to US customers typically routes through standard pharmaceutical wholesalers and specialty distributors under agreements with the brand holder. Named distributors depend on the current NDC distribution footprint and pharmacy channel arrangements.
Which suppliers matter most for continuity of supply of Tirosint?
Answer (high level): The risk concentration sits at:
- Levothyroxine sodium API qualification and lot availability
- Capsule filling and packaging line capacity (capsule shell supply, filling equipment uptime)
- Regulatory-approved quality systems across contract manufacturing sites
- Source continuity for excipients and packaging components (bottles, blister materials, desiccants)
Supplier risk map
| Supply-chain link |
Main constraint |
Supplier dependency |
Typical failure mode |
| Levothyroxine sodium API |
Batch release and impurity limits |
Qualified API vendor set |
API lot rejection or allocation |
| Capsule shell supply |
Gelatin sourcing and quality |
Capsule shell vendors |
Raw material shortage |
| Filling/packaging |
Line uptime and change control |
CMOs and packaging plants |
Capacity bottleneck during demand spikes |
| Finished-goods logistics |
Cold chain usually not required, but moisture control is |
Logistics provider |
Warehouse product damage or recall holds |
How do supplier choices affect Tirosint competition with generics?
Answer (high level): For levothyroxine sodium, competitor differentiation in the market is often tied to bioequivalence performance, capsule/solution handling consistency, and lot-to-lot dissolution control. Supplier variance can influence:
- Dissolution rate consistency
- Impurity profile stability
- Manufacturing reproducibility
What generic entry risks exist for Tirosint based on supplier bottlenecks?
Answer (high level): Generic entrants can face delays if they cannot source:
- API meeting the required quality specs at scale
- capsule shells/excipients at qualifying grades
- packaging materials that pass stability and line-speed constraints
Supplier bottlenecks can also protect branded supply during allocation events, but they do not stop legal expiration-driven entry if exclusivity ends.
What global suppliers provide Tirosint outside the US?
Answer (high level): Tirosint is distributed in multiple markets via country-level distributors under the brand owner’s umbrella. International “suppliers” (manufacturing sites, wholesalers) vary by local regulatory requirements and contract networks.
Practical coverage approach used by buyers
- Use country-specific labels and marketing authorizations to identify local manufacturing sites
- Cross-check with local regulatory databases and GMP inspectorate records
- Validate API source and manufacturer by lot documentation (CoA traceability)
Key Takeaways
- Tirosint is supplied under the brand ecosystem led by IBSA, using contract and/or owned manufacturing for dosage and packaging and qualified supplier sourcing for levothyroxine sodium API.
- Named “API supplier” and “exact manufacturing site supplier list” requires FDA/label establishment and lot-level documentation, which is not included in the prompt.
- Continuity of supply risk concentrates in API availability, capsule filling/packaging capacity, and capsule shell and packaging component supply.
FAQs
- Who owns the Tirosint brand in the US?
- Is Tirosint manufactured in-house or by contract manufacturers?
- Do Tirosint API suppliers change by lot?
- Which distributors typically supply Tirosint to pharmacies and hospitals?
- How do capsule and packaging suppliers affect levothyroxine product consistency?
References
- FDA Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. US FDA.
- Tirosint Prescribing Information (product label). US FDA label repository.
- FDA Drug Establishment Registration and Listing (DE/RL). US FDA.
